SI1119571T1 - Tricyclic delta3-piperidines as alpha2-antagonists - Google Patents

Tricyclic delta3-piperidines as alpha2-antagonists

Info

Publication number
SI1119571T1
SI1119571T1 SI9930264T SI9930264T SI1119571T1 SI 1119571 T1 SI1119571 T1 SI 1119571T1 SI 9930264 T SI9930264 T SI 9930264T SI 9930264 T SI9930264 T SI 9930264T SI 1119571 T1 SI1119571 T1 SI 1119571T1
Authority
SI
Slovenia
Prior art keywords
alpha2
piperidines
antagonists
delta3
tricyclic
Prior art date
Application number
SI9930264T
Other languages
English (en)
Slovenian (sl)
Inventor
Ludo Edmond J. Janssen Pharmaceutica N.V. KENNIS
DEN KEYBUS F.M.A. Janssen Pharmaceutica N.V. VAN
Josephus C. Janssen Pharmaceutica N.V. MERTENS
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of SI1119571T1 publication Critical patent/SI1119571T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
SI9930264T 1998-10-06 1999-10-01 Tricyclic delta3-piperidines as alpha2-antagonists SI1119571T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98203370 1998-10-06
PCT/EP1999/007419 WO2000020421A2 (en) 1998-10-06 1999-10-01 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS
EP99950627A EP1119571B1 (en) 1998-10-06 1999-10-01 Tricyclic delta3-piperidines as alpha2-antagonists

Publications (1)

Publication Number Publication Date
SI1119571T1 true SI1119571T1 (en) 2003-08-31

Family

ID=8234191

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930264T SI1119571T1 (en) 1998-10-06 1999-10-01 Tricyclic delta3-piperidines as alpha2-antagonists

Country Status (31)

Country Link
US (1) US6495555B1 (xx)
EP (1) EP1119571B1 (xx)
JP (1) JP4590101B2 (xx)
KR (1) KR20010071843A (xx)
CN (1) CN1131230C (xx)
AR (1) AR024216A1 (xx)
AT (1) ATE232869T1 (xx)
AU (1) AU760502B2 (xx)
BG (1) BG64872B1 (xx)
BR (1) BR9913507A (xx)
CA (1) CA2345622C (xx)
CZ (1) CZ20011104A3 (xx)
DE (1) DE69905478T2 (xx)
DK (1) DK1119571T3 (xx)
EE (1) EE04770B1 (xx)
ES (1) ES2193751T3 (xx)
HK (1) HK1038010A1 (xx)
HU (1) HUP0104002A3 (xx)
ID (1) ID28032A (xx)
IL (1) IL142443A0 (xx)
NO (1) NO20011270D0 (xx)
NZ (1) NZ510115A (xx)
PL (1) PL347894A1 (xx)
PT (1) PT1119571E (xx)
RU (1) RU2230744C2 (xx)
SI (1) SI1119571T1 (xx)
SK (1) SK285585B6 (xx)
TR (1) TR200100952T2 (xx)
TW (1) TWI248441B (xx)
UA (1) UA69420C2 (xx)
WO (1) WO2000020421A2 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010071844A (ko) * 1998-10-06 2001-07-31 디르크 반테 의약으로서의 트리사이클릭 δ3-피페리딘
ES2367481T3 (es) * 2002-04-03 2011-11-03 Orion Corporation Uso de un antagonista del adrenoreceptor alfa2 para enfermedades relacionadas con el snc.
MXPA06011777A (es) 2004-04-12 2007-01-16 Taisho Pharma Co Ltd Compuesto de amina ciclico.
EP1775283A4 (en) * 2004-07-14 2008-12-10 Japan Tobacco Inc 3-AMINOBENZAMIDE COMPOUND AND INHIBITORS OF THE ACTIVITY OF VANILLOID RECEPTOR 1 (VR1)
CA2571133C (en) * 2004-07-15 2011-04-19 Japan Tobacco Inc. Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor
US7906508B2 (en) * 2005-12-28 2011-03-15 Japan Tobacco Inc. 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (VRI) activity
BRPI1012205A2 (pt) 2009-05-14 2019-04-02 Janssen Pharmaceutica Nv compostos com duas porções heteroarila bicíclica fundidas como moduladores de leucotrieno a4 hidrolase
JOP20200052A1 (ar) 2013-12-19 2017-06-16 Bayer Pharma AG بيبريدينيل تتراهيدرو كوينولينات مستبدلة واستخدامها كمعضدات مستقبل أدريني ألفا- 2c
TN2016000249A1 (en) 2013-12-19 2017-10-06 Bayer Pharma AG Substituted piperidinyl-tetrahydroquinolines.
EP3083610A1 (de) 2013-12-19 2016-10-26 Bayer Pharma Aktiengesellschaft Substituierte bipiperidinyl-derivate als adrenrezeptor alpha 2c antagonisten
CN114276359B (zh) * 2022-01-05 2023-05-05 浙江大学 一种1,2,3,4-四氢苯并[4,5]呋喃[2,3-c]吡啶衍生物的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3522959A1 (de) * 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
EP0339959A3 (en) * 1988-04-27 1991-03-20 Glaxo Group Limited Lactam derivatives
US4971974A (en) 1988-06-16 1990-11-20 Neurex Corporation Benzothiophenes as appetite suppressants
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
NZ335711A (en) * 1996-12-06 2000-10-27 Abbott Lab Substituted benzopyranopyrrole and benzopyranopyridine derivatives
ATE290527T1 (de) 1997-12-25 2005-03-15 Meiji Seika Kaisha Tetrahydrobenzindol-derivate
KR20010071844A (ko) * 1998-10-06 2001-07-31 디르크 반테 의약으로서의 트리사이클릭 δ3-피페리딘

Also Published As

Publication number Publication date
CZ20011104A3 (cs) 2001-12-12
IL142443A0 (en) 2002-03-10
TWI248441B (en) 2006-02-01
KR20010071843A (ko) 2001-07-31
BG64872B1 (bg) 2006-07-31
UA69420C2 (uk) 2004-09-15
JP2002526545A (ja) 2002-08-20
HK1038010A1 (en) 2002-03-01
WO2000020421A2 (en) 2000-04-13
CA2345622C (en) 2007-12-04
AU6334199A (en) 2000-04-26
JP4590101B2 (ja) 2010-12-01
BG105332A (en) 2001-11-30
PL347894A1 (en) 2002-04-22
AU760502B2 (en) 2003-05-15
EP1119571B1 (en) 2003-02-19
CA2345622A1 (en) 2000-04-13
PT1119571E (pt) 2003-06-30
EE200100209A (et) 2002-06-17
ID28032A (id) 2001-05-03
AR024216A1 (es) 2002-09-25
DE69905478T2 (de) 2004-03-18
SK285585B6 (sk) 2007-04-05
CN1131230C (zh) 2003-12-17
DE69905478D1 (de) 2003-03-27
NO20011270L (no) 2001-03-13
RU2230744C2 (ru) 2004-06-20
HUP0104002A3 (en) 2003-12-29
EE04770B1 (et) 2007-02-15
DK1119571T3 (da) 2003-05-26
US6495555B1 (en) 2002-12-17
TR200100952T2 (tr) 2001-10-22
SK4322001A3 (en) 2002-01-07
ES2193751T3 (es) 2003-11-01
WO2000020421A3 (en) 2000-08-03
NZ510115A (en) 2002-11-26
CN1332744A (zh) 2002-01-23
EP1119571A2 (en) 2001-08-01
ATE232869T1 (de) 2003-03-15
HUP0104002A2 (hu) 2002-03-28
NO20011270D0 (no) 2001-03-13
BR9913507A (pt) 2001-06-05

Similar Documents

Publication Publication Date Title
PL345589A1 (en) β-CARBOLINE COMPOUNDS
IL137511A0 (en) Novel tricyclic compound
GB9804734D0 (en) Compounds
GB2338672B (en) Toolholder
EA199900301A3 (ru) Замещенные трициклические соединения.
GB9804175D0 (en) Compounds
PL345283A1 (en) Biphenyl derivatives
EA199900304A3 (ru) Замещенные трициклические соединения.
HK1038010A1 (en) Tricyclic delta3-piperidines as alpha2-antagonists
GB9816729D0 (en) Substituted cyclohexylaminopyrimidines
HK1039937A1 (zh) 取代的3-硫代氨基甲酰基吡唑類化合物
CZ20012041A3 (cs) Benzofuranové deriváty
IL142444A0 (en) TRICYCLIC δ3-PIPERIDINES AS PHARMACEUTICALS
HUP0102220A3 (en) Biphenyl derivatives
PL347397A1 (en) Substituted 3-aryl-pyrazoles
GB9809823D0 (en) Compounds
HUP0102476A3 (en) Substituted cyclooctadepsipeptides
HK1039335A1 (zh) 取代的苯甲酰基環已二酮類化合物
GB9810876D0 (en) Compounds
EP1105133A4 (en) TRICYCLIC CONNECTIONS
GB2336672B (en) Level
GB9801712D0 (en) Compounds
GB9809217D0 (en) Compounds
TW342936U (en) Level
GB9817401D0 (en) Novel compunds